• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名系统性硬化症患者因波生坦引起的药疹。

Drug eruption due to bosentan in a patient with systemic sclerosis.

作者信息

Nagai Yayoi, Yamanaka Masayoshi, Nishimura Shigeru, Nakano Akihiko, Hasegawa Akira, Ishikawa Osamu

机构信息

Department of Dermatology, Gunma University Graduate School of Medicine, 3-39-22 Showamachi, Maebashi, 371-8511, Japan.

出版信息

Mod Rheumatol. 2006;16(3):188-90. doi: 10.1007/s10165-006-0477-3.

DOI:10.1007/s10165-006-0477-3
PMID:16767560
Abstract

We present the case of a 60-year-old female patient with systemic sclerosis complicated by pulmonary hypertension. Ten days after the initiation of treatment with bosentan, high fever and skin eruptions were noted. In the previous reports, the frequency of drug-induced skin eruptions has not been well documented. Since the use of bosentan is expected to increase, we should be aware of the previously unknown adverse effects as well as skin eruptions.

摘要

我们报告一例60岁女性患者,患有系统性硬化症并伴有肺动脉高压。在开始使用波生坦治疗10天后,出现了高热和皮疹。在以往的报告中,药物性皮疹的发生率尚无充分记录。鉴于波生坦的使用预计会增加,我们应该意识到此前未知的不良反应以及皮疹。

相似文献

1
Drug eruption due to bosentan in a patient with systemic sclerosis.一名系统性硬化症患者因波生坦引起的药疹。
Mod Rheumatol. 2006;16(3):188-90. doi: 10.1007/s10165-006-0477-3.
2
Endothelin receptor antagonist bosentan improves the dermal sclerosis in a patient with systemic sclerosis.内皮素受体拮抗剂波生坦改善系统性硬皮病患者的皮肤硬化。
Australas J Dermatol. 2012 May;53(2):e32-3. doi: 10.1111/j.1440-0960.2010.00719.x. Epub 2010 Nov 29.
3
Severe hepatotoxicity in a patient on bosentan upon addition of methotrexate: reversible with resumption of methotrexate without bosentan.波生坦治疗的患者加用甲氨蝶呤后出现严重肝毒性:停用波生坦后恢复甲氨蝶呤治疗,肝毒性可逆转。
J Clin Rheumatol. 2009 Mar;15(2):88-9. doi: 10.1097/RHU.0b013e31819bc71f.
4
Ironic case of hepatic dysfunction following the global withdrawal of sitaxentan.西他生坦全球撤市后肝功能异常的罕见病例报告。
Intern Med J. 2012 Dec;42(12):1351-4. doi: 10.1111/imj.12007.
5
[Bosentan: a considerable increase in the survival of patients with pulmonary hypertension associated with systemic rheumatic diseases].波生坦:与系统性风湿性疾病相关的肺动脉高压患者生存率显著提高
Ter Arkh. 2014;86(5):32-9.
6
Endothelin-I receptor antagonist for the treatment of pulmonary arterial hypertension in systemic sclerosis.用于治疗系统性硬化症相关肺动脉高压的内皮素-1受体拮抗剂
Curr Rheumatol Rep. 2003 Apr;5(2):145-6. doi: 10.1007/s11926-003-0042-4.
7
Bosentan in systemic sclerosis.波生坦治疗系统性硬化症。
Drugs Today (Barc). 2008 Jun;44(6):415-28. doi: 10.1358/dot.2008.44.6.1220138.
8
Liver impairment after concomitant administration of bosentan and clarithromycin in systemic sclerosis.系统性硬化症患者同时服用波生坦和克拉霉素后出现肝功能损害。
Joint Bone Spine. 2010 Jan;77(1):81-2. doi: 10.1016/j.jbspin.2009.04.010. Epub 2009 Dec 22.
9
Resolution of severe digital ulceration during a course of Bosentan therapy.波生坦治疗过程中严重指端溃疡的消退
Ann Intern Med. 2005 May 3;142(9):802-3. doi: 10.7326/0003-4819-142-9-200505030-00029.
10
Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study.双重内皮素受体拮抗剂波生坦治疗肺动脉高压患者的疗效:一项随机安慰剂对照研究。
Lancet. 2001 Oct 6;358(9288):1119-23. doi: 10.1016/S0140-6736(01)06250-X.

引用本文的文献

1
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome and the Rheumatologist.药物超敏反应伴嗜酸性粒细胞增多和全身症状(DRESS)综合征与风湿病学家。
Curr Rheumatol Rep. 2017 Jan;19(1):3. doi: 10.1007/s11926-017-0626-z.